RLMD
Relmada Therapeutics, Inc. · Healthcare
Director Charles J Casamento sold $114K of Relmada Therapeutics, Inc.
Sold$113,956
$37.99Price
3,000Shares
−5%Stake
What RLMD did after the filing
- The stock from Fri, Oct 2 close, $39.22
- −17.0%
- S&P 500, same days
- +7.3%
Measured over 30 trading days, to the Nov 13 close.
Traded Thu, Oct 1. Filed Fri, Oct 2, 12:02 PM ET, during the session. Returns use the Oct 2 close and the Nov 13 close. Not investment advice.